Naprosyn (Naproxen)

Naproxen, the active ingredient in Naprosyn, is a nonsteroidal anti-inflammatory drug presented as an oral formulation for oral use. It treats mild to moderate pain, inflammatory joint conditions, dysmenorrhea and fever in adult patients. GNH USA supplies Naprosyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naprosyn belongs to the NSAID class and is employed for conditions involving pain and inflammation. - Mild to moderate pain: provides analgesic relief for acute or chronic pain states. - Rheumatoid arthritis: reduces joint inflammation and improves mobility. - Osteoarthritis: alleviates chronic joint pain and stiffness. - Dysmenorrhea: eases menstrual cramp discomfort. - Fever: lowers elevated body temperature associated with inflammatory processes.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation. - Increased blood pressure. - Mild renal function changes.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic enzyme elevation or liver injury. - Acute kidney injury or worsening of chronic renal disease. - Anaphylaxis or severe hypersensitivity reactions.

Before initiating therapy, consider the following safety measures. - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Evaluate cardiovascular profile: use cautiously in those with heart disease or stroke risk. - Monitor renal function: adjust or discontinue if renal impairment develops. - Use the lowest effective dose for the shortest duration required. - Avoid in individuals with known hypersensitivity to naproxen or other NSAIDs. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Naproxen can affect the activity of several concomitant medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Diuretics: may enhance renal impairment. - Methotrexate: naproxen can raise methotrexate plasma levels, increasing toxicity.